;

Home >>

Global Flu (Influenza) Vaccine Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 106 | Code: MRS - 772865

The Flu (Influenza) Vaccine market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Flu (Influenza) Vaccine market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Flu (Influenza) Vaccine market. The report focuses on well-known providers in the global Flu (Influenza) Vaccine industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Flu (Influenza) Vaccine Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Flu (Influenza) Vaccine market covered in Chapter 4:
Pfizer
Merck & Co
Emergent BioSolutions
GlaxoSmithKline
CSL (Novartis)
Bavarian Nordic
Sanofi Pasteur
Inovio Pharmaceuticals
Mitsubishi Tanabe Pharma
Novavax

In Chapter 11 and 13.3, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2026 is primarily split into:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)

In Chapter 12 and 13.4, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2026 covers:
For Children (6 months to 3 years)
For Adults and Children over 3 years

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Flu (Influenza) Vaccine Market Share by Type (2020-2026)
1.5.2 Inactivated Influenza Vaccines (IIV)
1.5.3 Live Attenuated Influenza Vaccines (LAIV)
1.6 Market by Application
1.6.1 Global Flu (Influenza) Vaccine Market Share by Application (2020-2026)
1.6.2 For Children (6 months to 3 years)
1.6.3 For Adults and Children over 3 years
1.7 Flu (Influenza) Vaccine Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Flu (Influenza) Vaccine Market
3.1 Value Chain Status
3.2 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine
3.2.3 Labor Cost of Flu (Influenza) Vaccine
3.2.3.1 Labor Cost of Flu (Influenza) Vaccine Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Pfizer
4.1.1 Pfizer Basic Information
4.1.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.1.3 Pfizer Flu (Influenza) Vaccine Market Performance (2015-2020)
4.1.4 Pfizer Business Overview
4.2 Merck & Co
4.2.1 Merck & Co Basic Information
4.2.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.2.3 Merck & Co Flu (Influenza) Vaccine Market Performance (2015-2020)
4.2.4 Merck & Co Business Overview
4.3 Emergent BioSolutions
4.3.1 Emergent BioSolutions Basic Information
4.3.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.3.3 Emergent BioSolutions Flu (Influenza) Vaccine Market Performance (2015-2020)
4.3.4 Emergent BioSolutions Business Overview
4.4 GlaxoSmithKline
4.4.1 GlaxoSmithKline Basic Information
4.4.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.4.3 GlaxoSmithKline Flu (Influenza) Vaccine Market Performance (2015-2020)
4.4.4 GlaxoSmithKline Business Overview
4.5 CSL (Novartis)
4.5.1 CSL (Novartis) Basic Information
4.5.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.5.3 CSL (Novartis) Flu (Influenza) Vaccine Market Performance (2015-2020)
4.5.4 CSL (Novartis) Business Overview
4.6 Bavarian Nordic
4.6.1 Bavarian Nordic Basic Information
4.6.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.6.3 Bavarian Nordic Flu (Influenza) Vaccine Market Performance (2015-2020)
4.6.4 Bavarian Nordic Business Overview
4.7 Sanofi Pasteur
4.7.1 Sanofi Pasteur Basic Information
4.7.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.7.3 Sanofi Pasteur Flu (Influenza) Vaccine Market Performance (2015-2020)
4.7.4 Sanofi Pasteur Business Overview
4.8 Inovio Pharmaceuticals
4.8.1 Inovio Pharmaceuticals Basic Information
4.8.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.8.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Market Performance (2015-2020)
4.8.4 Inovio Pharmaceuticals Business Overview
4.9 Mitsubishi Tanabe Pharma
4.9.1 Mitsubishi Tanabe Pharma Basic Information
4.9.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.9.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Market Performance (2015-2020)
4.9.4 Mitsubishi Tanabe Pharma Business Overview
4.10 Novavax
4.10.1 Novavax Basic Information
4.10.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification
4.10.3 Novavax Flu (Influenza) Vaccine Market Performance (2015-2020)
4.10.4 Novavax Business Overview

5 Global Flu (Influenza) Vaccine Market Analysis by Regions
5.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
5.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
5.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
5.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6 North America Flu (Influenza) Vaccine Market Analysis by Countries
6.1 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
6.1.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
6.1.3 North America Flu (Influenza) Vaccine Market Under COVID-19
6.2 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.2.1 United States Flu (Influenza) Vaccine Market Under COVID-19
6.3 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.4 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7 Europe Flu (Influenza) Vaccine Market Analysis by Countries
7.1 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)
7.1.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
7.1.3 Europe Flu (Influenza) Vaccine Market Under COVID-19
7.2 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.2.1 Germany Flu (Influenza) Vaccine Market Under COVID-19
7.3 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.3.1 UK Flu (Influenza) Vaccine Market Under COVID-19
7.4 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.4.1 France Flu (Influenza) Vaccine Market Under COVID-19
7.5 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.5.1 Italy Flu (Influenza) Vaccine Market Under COVID-19
7.6 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.6.1 Spain Flu (Influenza) Vaccine Market Under COVID-19
7.7 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.7.1 Russia Flu (Influenza) Vaccine Market Under COVID-19

8 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Countries
8.1 Asia-Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Flu (Influenza) Vaccine Market Under COVID-19
8.2 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.2.1 China Flu (Influenza) Vaccine Market Under COVID-19
8.3 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.3.1 Japan Flu (Influenza) Vaccine Market Under COVID-19
8.4 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.4.1 South Korea Flu (Influenza) Vaccine Market Under COVID-19
8.5 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.6.1 India Flu (Influenza) Vaccine Market Under COVID-19
8.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Flu (Influenza) Vaccine Market Under COVID-19

9 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Countries
9.1 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Flu (Influenza) Vaccine Market Under COVID-19
9.2 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.3 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.5 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.6 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10 South America Flu (Influenza) Vaccine Market Analysis by Countries
10.1 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries
10.1.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)
10.1.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)
10.1.3 South America Flu (Influenza) Vaccine Market Under COVID-19
10.2 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.2.1 Brazil Flu (Influenza) Vaccine Market Under COVID-19
10.3 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.4 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10.5 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

11 Global Flu (Influenza) Vaccine Market Segment by Types
11.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)
11.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)
11.2 Inactivated Influenza Vaccines (IIV) Sales and Price (2015-2020)
11.3 Live Attenuated Influenza Vaccines (LAIV) Sales and Price (2015-2020)

12 Global Flu (Influenza) Vaccine Market Segment by Applications
12.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)
12.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)
12.2 For Children (6 months to 3 years) Sales, Revenue and Growth Rate (2015-2020)
12.3 For Adults and Children over 3 years Sales, Revenue and Growth Rate (2015-2020)

13 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)
13.1 Global Flu (Influenza) Vaccine Sales, Revenue and Growth Rate (2020-2026)
13.2 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)
13.2.1 North America Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.2 Europe Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.2.5 South America Flu (Influenza) Vaccine Market Forecast (2020-2026)
13.3 Flu (Influenza) Vaccine Market Forecast by Types (2020-2026)
13.4 Flu (Influenza) Vaccine Market Forecast by Applications (2020-2026)
13.5 Flu (Influenza) Vaccine Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing